ID

19632

Descripción

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00533936

Link

https://clinicaltrials.gov/show/NCT00533936

Palabras clave

Versiones (1)
  1. 17/1/17 17/1/17 -
Subido en

17 de enero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00533936

Inglés

Eligibility Breast Cancer NCT00533936

1 formularios  
Criteria
Descripción

Criteria

histologically confirmed invasive breast cancer by needle biopsy
Descripción

Invasive carcinoma of breast Needle biopsy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0005560
diagnosed within the past 4 weeks
Descripción

Diagnosis Timepoint

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011900
UMLS CUI [1,2]
C2348792
clinical stage iib, iiia, iiib, or iiic disease
Descripción

Disease TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3258246
palpable adenopathies present
Descripción

Lymphadenopathy Palpable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0497156
UMLS CUI [1,2]
C0522499
her2/neu-positive disease, as evidenced by either of the following:
Descripción

HER2-positive carcinoma of breast Evidence of

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1960398
UMLS CUI [1,2]
C0332120
her2/neu overexpression (3+) by immunohistochemistry (ihc)
Descripción

ERBB2 Protein Overexpression Immunohistochemistry

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1515560
UMLS CUI [1,2]
C0021044
her2/neu amplification by fluorescence in situ hybridization (fish)
Descripción

HER2 gene amplification Fluorescent in Situ Hybridization

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512127
UMLS CUI [1,2]
C0162789
no metastatic disease by chest radiography, hepatic ultrasound, and bone scan (metastatic bone series if no nuclear medicine is available)
Descripción

Neoplasm Metastasis Plain chest X-ray | Ultrasonography of liver | Radioisotope scan of bone

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0039985
UMLS CUI [2]
C0412534
UMLS CUI [3]
C0203668
hormone receptor status:
Descripción

Hormone Receptor Status

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
estrogen receptor and/or progesterone receptor status known
Descripción

Estrogen Receptor Status Known | Progesterone Receptor Status Known

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0034804
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0205309
UMLS CUI [2,1]
C0034833
UMLS CUI [2,2]
C0449438
UMLS CUI [2,3]
C0205309
patient characteristics:
Descripción

Client Characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0815172
premenopausal or postmenopausal
Descripción

Premenopausal state | Postmenopausal state

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C0232970
who performance status 0-2
Descripción

WHO performance status scale

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1298650
not pregnant or nursing
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
normal hepatic, renal, and hematological function
Descripción

Liver function | Renal function | Hematologic function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0221130
lvef ≥ 55% by nuclear medicine study or echocardiogram
Descripción

Left ventricular ejection fraction Nuclear medicine procedure | Echocardiography

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0428772
UMLS CUI [1,2]
C0203634
UMLS CUI [2]
C0013516
no prior history of cancer, except carcinoma in situ of the cervix
Descripción

Malignant Neoplasms | Carcinoma in situ of uterine cervix

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0851140
no allergic reaction or hypersensitivity to paclitaxel and/or trastuzumab (herceptin®)
Descripción

Paclitaxel allergy | Hypersensitivity trastuzumab | Hypersensitivity Herceptin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0570707
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0728747
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0338204
prior concurrent therapy:
Descripción

Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0087111
no prior cancer therapy
Descripción

cancer treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0920425
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00533936

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Invasive carcinoma of breast Needle biopsy
Item
histologically confirmed invasive breast cancer by needle biopsy
boolean
C0853879 (UMLS CUI [1,1])
C0005560 (UMLS CUI [1,2])
Diagnosis Timepoint
Item
diagnosed within the past 4 weeks
boolean
C0011900 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
Disease TNM clinical staging
Item
clinical stage iib, iiia, iiib, or iiic disease
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Lymphadenopathy Palpable
Item
palpable adenopathies present
boolean
C0497156 (UMLS CUI [1,1])
C0522499 (UMLS CUI [1,2])
HER2-positive carcinoma of breast Evidence of
Item
her2/neu-positive disease, as evidenced by either of the following:
boolean
C1960398 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
ERBB2 Protein Overexpression Immunohistochemistry
Item
her2/neu overexpression (3+) by immunohistochemistry (ihc)
boolean
C1515560 (UMLS CUI [1,1])
C0021044 (UMLS CUI [1,2])
HER2 gene amplification Fluorescent in Situ Hybridization
Item
her2/neu amplification by fluorescence in situ hybridization (fish)
boolean
C1512127 (UMLS CUI [1,1])
C0162789 (UMLS CUI [1,2])
Neoplasm Metastasis Plain chest X-ray | Ultrasonography of liver | Radioisotope scan of bone
Item
no metastatic disease by chest radiography, hepatic ultrasound, and bone scan (metastatic bone series if no nuclear medicine is available)
boolean
C0027627 (UMLS CUI [1,1])
C0039985 (UMLS CUI [1,2])
C0412534 (UMLS CUI [2])
C0203668 (UMLS CUI [3])
Hormone Receptor Status
Item
hormone receptor status:
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
Estrogen Receptor Status Known | Progesterone Receptor Status Known
Item
estrogen receptor and/or progesterone receptor status known
boolean
C0034804 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205309 (UMLS CUI [1,3])
C0034833 (UMLS CUI [2,1])
C0449438 (UMLS CUI [2,2])
C0205309 (UMLS CUI [2,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Premenopausal state | Postmenopausal state
Item
premenopausal or postmenopausal
boolean
C0232969 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
WHO performance status scale
Item
who performance status 0-2
boolean
C1298650 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Liver function | Renal function | Hematologic function
Item
normal hepatic, renal, and hematological function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0221130 (UMLS CUI [3])
Left ventricular ejection fraction Nuclear medicine procedure | Echocardiography
Item
lvef ≥ 55% by nuclear medicine study or echocardiogram
boolean
C0428772 (UMLS CUI [1,1])
C0203634 (UMLS CUI [1,2])
C0013516 (UMLS CUI [2])
Malignant Neoplasms | Carcinoma in situ of uterine cervix
Item
no prior history of cancer, except carcinoma in situ of the cervix
boolean
C0006826 (UMLS CUI [1])
C0851140 (UMLS CUI [2])
Paclitaxel allergy | Hypersensitivity trastuzumab | Hypersensitivity Herceptin
Item
no allergic reaction or hypersensitivity to paclitaxel and/or trastuzumab (herceptin®)
boolean
C0570707 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0728747 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0338204 (UMLS CUI [3,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
cancer treatment
Item
no prior cancer therapy
boolean
C0920425 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial